-
Mashup Score: 11Sotorasib - KRAS G12C- A regulatory failure - 1 year(s) ago
Two recent papers — by Fojo and Olivier — tell the full story
Source: developdrugs.substack.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 24How to read and interpret a cancer clinical trial - 1 year(s) ago
A concise, step by step guide
Source: developdrugs.substack.comCategories: General Medicine News, Hem/OncsTweet-
How to read and interpret a cancer clinical trial: A concise, step by step guide https://t.co/VmI7NDDpQj via @VPrasadMDMPH https://t.co/3EJySuKSjX
-
-
Mashup Score: 24How to read and interpret a cancer clinical trial - 1 year(s) ago
A concise, step by step guide
Source: developdrugs.substack.comCategories: General Medicine News, Hem/OncsTweet-
How to read and interpret a cancer clinical trial: A concise, step by step guide https://t.co/VmI7NDDpQj via @VPrasadMDMPH https://t.co/3EJySuKSjX
-
-
Mashup Score: 12CAR T cells linked to secondary AML/MDS - 1 year(s) ago
We cover all aspects of pharmaceutical drug development; early, late phase and FDA pivotal trials; Focus on oncology, but also cover important cardiology, neurology and drugs for rare diseases
Source: developdrugs.substack.comCategories: General Medicine News, Hem/OncsTweet-
We discuss the CAR T myeloma safety signal on the Drug Development Letter @ManniMD1 @rajshekharucms @AaronGoodman33 https://t.co/TJqmy7EN5u
-
-
Mashup Score: 12The Drug Development Letter | Vinay Prasad | Substack - 1 year(s) ago
Thousands of subscribers. We cover all aspects of pharmaceutical drug development; early, late phase and FDA pivotal trials; Focus on oncology, but also cover important cardiology, neurology and drugs for rare diseases. Click to read The Drug Development Letter, by Vinay Prasad, a Substack publication.
Source: developdrugs.substack.comCategories: General Medicine News, Hem/OncsTweet-
Skim up to date Skim nccn Think about the evidence for what they recommend and what smells fishy and dig deeper Listen to critical podcasts https://t.co/kTFZeJz6tC https://t.co/M3qLqpwmtE
-
-
Mashup Score: 8How to read and interpret Kaplan Meier Curves - 2 year(s) ago
Slides available for subscribers
Source: developdrugs.substack.comCategories: General Medicine News, Expert PicksTweet-
Slides here https://t.co/di29BqeDp7
-
-
Mashup Score: 10
Do you really benefit from DOAC in year 5, 6 or 17
Source: developdrugs.substack.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Just out in the Drug Development letter, I break down our recent paper on extended anticoagulation Do we really know patients are better off when we anticoagulate them into year 7 or 17? https://t.co/1K9Cak6Mmz https://t.co/J1P7fRbH2u
-
-
Mashup Score: 6How much money do we waste when cancer patients change dose and throw out their pills? - 2 year(s) ago
Our new paper in JAMA Oncology
Source: developdrugs.substack.comCategories: Expert Picks, Latest HeadlinesTweet-
Just out on the Drug Development letter https://t.co/Ajvq7G0kpy https://t.co/8S6QWkE2cH
-
-
Mashup Score: 2
Our new paper is out now in BMC Cancer
Source: developdrugs.substack.comCategories: Expert Picks, Latest HeadlinesTweet-
Everyone going to #ASCO23 should read this It is the KEY to interpreting OS results of #ADAURA What does the control arm get at progression? -- is the key question If it is Get-fitinib, you can go ahead and Get-TFO @JackWestMD @Timothee_MD https://t.co/HGLkWtTFSF https://t.co/EYxkSIW7f2
-
Just out in Drug Development Letter @Timothee_MD discusses his paper in @BioMedCentral #BMCCancer on post-protocol therapy in RCTs used 4 FDA approval @FDAOncology not asking if new drugs improve outcomes in a backdrop of USA standard care Patients pay https://t.co/HGLkWtTFSF https://t.co/ThYmcWb3gI
-
-
Mashup Score: 21How to read and interpret a cancer clinical trial - 2 year(s) ago
A concise, step by step guide
Source: developdrugs.substack.comCategories: Expert Picks, Latest HeadlinesTweet-
This framework, which is adapted from the book Malignant, can help interpret pretty much any cancer trial https://t.co/R8P3wRhbnj https://t.co/neKJB56OT0
-
Everything you need to know about Sotorasib Will interest anyone interested in drug development Consider subscribing for more https://t.co/NW4h5ZfnLr https://t.co/aIAveaM8z7